It’s a story of mice and men with huge implications: Mayo Clinic researchers and collaborators from the UK have apparently cured mice with well-established prostate tumors with no visible side effects via a new kind of tumor vaccine. And if it works for men like it worked for mice, it could make prostate cancer a preventable condition and open the door to additional cancer vaccines.
The findings are preliminary but promising. Geneticists basically assembled a complementary DNA library from healthy prostate tissue and inserted snippets of that genetic code into a swarm of viruses that were introduced to the mice intravenously. This cDNA causes the viruses to produce prostate antigens, basically sending the immune system a distress signal with the prostate’s unique signature on it.
One of the reasons the body often can’t beat cancerous growths on its own is because it can’t see the tumor cells very well, so the immune system doesn’t know where to fight its battles even as the cancer takes more ground. But those engineered viruses expressing those prostate antigens--antigens are like molecular tags indicative of a specific infection, allergen, pathogen, etc.--basically raise the visibility of the problem at the prostate.This causes the mice’s own body to mount a serious T-cell assault on the prostate and anything foreign that might be hiding out there. So the body basically thinks it’s being invaded by viruses expressing these cancer related antigens, but it doesn’t really matter what the immune system thinks. When the dust settles, the immune system has pounded the prostate with defensive measures, eradicating the tumor cells there.
That’s big news for men, and could be big news for anyone affected by a variety of cancers, including lung, pancreatic, and even brain cancers. Immunologists have long sought (with limited success) to isolate and catalog all the various antigens in tumor cells, but by using viruses and cDNA treatments can be less precise and still raise the alarm within the immune system, triggering a cancer-killing response.
Five amazing, clean technologies that will set us free, in this month's energy-focused issue. Also: how to build a better bomb detector, the robotic toys that are raising your children, a human catapult, the world's smallest arcade, and much more.


Online Content Director: Suzanne LaBarre | Email
Senior Editor: Paul Adams | Email
Associate Editor: Dan Nosowitz | Email
Assistant Editor: Colin Lecher | Email
Assistant Editor: Rose Pastore | Email
Contributing Writers:
Rebecca Boyle | Email
Kelsey D. Atherton | Email
Francie Diep | Email
Shaunacy Ferro | Email
These implications are bigger than huge. As a thirty-something male, I don't believe that this research can proceed fast enough!
And it's far-reaching, as well. This treatment can potentially be applied to just about any type of cancer.
Fund this like you just won the Powerball *and* there's no tomorrow!
!!!
I don't know what more to say than: !!! !
It's just amazing!
I guess the main thing they would need to worry about is making sure the viruses don't attack other parts of the body and set off an autoimmune response, destroying things like brain cells.
Omg, I just thought...
Once is this in widespread use, immunity to these various cancers will become more common as more and more people are inoculated due to coming down with a specific type of cancer.
But then, mothers who breastfeed their children and pass along their immunities... may also be passing along an immunity to a certain type of cancer! Now I'm not an expert on the subject, but it seems to me that within a dozen generations or so, humanity might no longer need to be inoculated against many, or even any, types of cancer. We may someday actually be immune.
What a concept.
If this is true, you can bet your ass that the pharmaceutical and healthcare industry isn't going to take this laying down.
Do you realize how many billions of dollars they're going to loose on cancer care? My concern is not for the safety of the cure, but the revenge of the healthcare machine...
I Am Legend
It doesn't sound like this is a 'vaccine' in the sense that I could get a shot in grade school and be immune for life. The problem is that cancer doesn't trigger a big enough immune response in your body - this kickstarts a temporary response which will give your body the message that 'I am sick'.
Give it a little more credit than that. It also tells your immune system WHERE you are sick. Which is the main point of why this works.
yep I Am Legend is what this is sounding like. im all for a cure of any sickness but first i need 1000% scientific satisfaction and approval.
Uh hold on. How do you get viruses expressing cancer related prostate antigens when you've given them cDNA from healthy prostate tissue?
it was just a matter of time.
Damnit! I've been drinking four cups of disgusting coffee each day for months now because it was shown to reduce the risk of prostate cancer!
*spits out coffee*
*smashes cup on the floor*
I'm not sure if I'm more thrilled about a possible cancer treatment, or the fact that I can go back to avoiding coffee!
Very interesting. Note that it's essentially a "prostate vaccine", not specifically a "prostate cancer vaccine"! I guess the healthy prostate cells are better able to fend off the body's autoimmune attack than the disregulated cancer cells.
Probably what makes this work is that the virus they're using already has a stronger affinity for cancer cells, and that healthy prostate cells are already partially screened from the immune system.
An interesting tightrope to walk, for sure...
Hmm... Apparently, they also get much better results with an "Altered-self epitope expressed library", where the "altered-self" part refers to the fact that they don't use a cDNA library from mouse but from human prostate, to cure prostate cancer in mice.
Because the human proteins are slightly different from the mouse ones, this makes it much easier to stimulate an autoimmune response in the mice. And presumably, once the human proteins are eliminated, the immune systems dampens down again, so you get a bigger initial bang for your buck, with less risk for a runaway autoimmune reaction.
Here's a link to the paper:
http://www.nature.com/nm/journal/vaop/ncurrent/abs/nm.2390.html